The Mark Foundation for Cancer Research announces grant to New York Genome Center

NEW YORK, NY — This week, The Mark Foundation for Cancer Research announced a $1M grant to the New York Genome Center (NYGC) to support a new, multi-institutional endeavor to study the genomics of cancer across the diverse communities of New York City.

This NYGC Project, Polyethnic-1000, aims ultimately to improve outcomes for patients by increasing the participation of ethnic groups currently underrepresented in existing genomic databases. Using state-of-the-art genomic sequencing and analysis, NYGC and its collaborators will create tools to assist physicians in selecting the best treatment for each individual patient. The data collected in this initiative will also enable researchers to tackle critical outstanding questions about tumor biology, cancer risk, and response to treatment across genetically diverse populations of patients.

Polyethnic-1000 was organized at NYGC by cancer experts Drs. Harold Varmus, Weill Cornell Medicine and NYGC, and Charles Sawyers, Memorial Sloan Kettering Cancer Center, with members of the NYGC’s Genome Center Cancer Group. The project will be led by Cold Spring Harbor Laboratory cancer researchers and NYGC affiliates, Drs. Fieke Froeling and David Tuveson, in partnership with NYGC computational biologist Dr. Nicolas Robine.

“In this study, we are creating a dynamic research platform within the greater New


Article originally posted at

Click here for the full story


Privacy Policy / Terms Of Use

       Powered by MMD